Regulation of growth hormone secretion

Hormone Research in Paediatrics

Volumn 46, Issue 4-5, 1996, Pages 149-154

  Scanlon, Maurice F ^a   Issa, Basil G ^a   Dieguez, Carlos ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Growth hormone; Neuroregulation

Indexed keywords

GLUCOCORTICOID; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SEX HORMONE; SOMATOMEDIN C; SOMATOSTATIN; THYROID HORMONE;

CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; CONFERENCE PAPER; FEEDBACK SYSTEM; GROWTH HORMONE RELEASE; HUMAN; HYPOTHALAMUS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL;

ANIMALS; FEEDBACK; GLUCOCORTICOIDS; GLUCOSE; GROWTH HORMONE; HOMEOSTASIS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OLIGOPEPTIDES; THYROID HORMONES;

EID: 0029820528     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185014     Document Type: Article

References (41)

1. Tannenbaum GS, Ling N: The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion, Endocrinology 1984: 115:1952-1957.
2. Plotsky POM, Vale W: Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial portal circulation of the rat, Science 1985;230:461-463.
3. Frohman LA, Downs TR, Clarke U, Thomas GB: Measurement of growth hormone releasing hormone and somatostatin in hypothalam-ic-portal plasma of unanesthetized sheep: Spontaneous secretion and response to insulin-induced hypoglycacmia, J Clin Invest 1990:86: 17-24.
4. Horvath S, Palkovits M: Synaptic interconnections among growth hormone-releasing hormone (GHRH) containing neurons in the arcuate nucleus of the hypothalamus, Neuroendocrinology 1988:48:471-476.
5. Aguila MC, McCann SM: Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via p-endorphin, Endoeri nology 1987:120:341-344.
6. Zeytin FN, Rusk SF, De Lellis R: Growth hormone-releasing factor and fibroblast growth factor regulate somatostatin gene expression, Endocrinology 1988:122:1133-1136.
7. Katakami H, Arimura A, Frohman LA: Growth hormone (GH) releasing factor stimulates hypothalamic somatostatin release: An inhibitory feedback effect on GH secretion, Endocrinology 1986:118:1872-1877.
8. Sugihara H, Minami S, Okado K, Kamegai J, Hasegawa O, Wakabavashi I: Somatostatin reduces transcription of the growth hormone gene in rats, Endocrinology 1993; 132:1225-1229.
9. Lamberts SW, van der Lely AJ, de Herder WW, Holland U: Octreotide, N Engl J Med 1996;334:246-254.
10. Ross RJ, Borges F, Grossman A, Smith R, Ngahfoong L, Rees LM, Savage MO, Bcsscr GM: Growth hormone prctreatment in man blocks the response to growth hormone-releasing hormone: Evidence for a direct effect of growth hormone, Clin Endocrinol 1987:26: 117-123.
11. Ross RJ, Tsagarakis S, Grossman A, Nhaga-foong L, Touzcl RJ, Rees LH, Besscr GM: GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: Studies with pyridostigmine and GHRH, Clin Endocrinol 1987;27:727-733.
12. Massara F, Ghigo E, Demislis K, Tangolo D, Mazza E, Locatclli V, Muller EE, Molinatti GM, Camanni F: Cholinergic involvement in the growth hormone releasing hormonc-in-dueed growth hormone release: Studies in normal and acromegalic subjects, Ncurocndocri-nology 1986;43:670-675.
13. Dieguez C, Page MD, Scanlon MF: Growth hormone ncuroregulation and its alterations in disease stales, Clin Endocrinol 1988:128:109-143.
14. Locatclli V, Torscllo A, Redaelli M, Ghigo E, Massara F, Muller EE: Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: Evidence for mediation by somatostatin, J Endocrinol 1986; 111:271-278.
15. Berclowitz M, Firestone SL, Frohman LA: Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution, Endocrinology 1981;109:714-719.
16. Chihara K, Minamitani N, Kaji H, Arimura A, Fukita T: Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood, Endocrinology 1981;109:2279-2281.
17. Lanzi R, Tannenbaum GS: Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: Role for somatostatin, Endocrinology 1992;130:1822-1828.
18. Jordan V, Dieguez C, Valcavi R, Artioli C, Por-tioli I, Rodriguez-Amao MD, Gomez-Pan A, Hall R, Scanlon MF: Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjects, Clin Endocrinol 1986;24:415-420.
19. Page MD, Koppeschaar HP, Dieguez C, Gibbs JT, Hall R, Peters JR, Scanlon MF: Cholinergic muscarinic receptor blockade with pirenzcpine abolishes slow wave sleep-related growth hormone release in young patients with insulin-dependent diabetes mcllitus, Clin Endocrinol 1987;25:355-359.
20. Atica JA, Crcagh F, Page M, Owens DR, Scanlon MF, Peters JR: Early morning hyperglv-eacmia in insulin-dependent diabetes: Acute and sustained effects of cholinergic blockade, J Clin Endocrinol Metab 1989:69:390-395.
21. Berclowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL: Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary', Science 1981;212:1279-1281.
22. Yamashita S, Melmed S: Insulin-like growth factor 1 regulation of growth hormone gene transcription in primary rat pituitary cells, J Clin Invest 1987:79:449-452.
23. Morita S, Yamashita S, Melmed S: Insulin-like growth factor-1 action on rat anterior pituitary cells: Effects of intracellular messengers on growth hormone secretion and messenger ribonucleic acid levels, Endocrinology 1987:121: 2000-2006.
24. Soto JL, Castrillo JL, Dominguez F, Dieguez C: Regulation of the pituitary-specific transcription factor GHF-I/Pit-I messenger ribonucleic acid levels by growth hormone secretagogues in rat anterior pituitary cells in monolayer culture, Endocrinology 1995;136:3863-3870.
25. Page MD, Koppeschaar HP, Edwards CA, Dieguez C, Scanlon MF: Additive effects of growth hormone releasing factor and insulin hypoglvcaemia on growth hormone release in man, Clin Endocrinol 1987:26:589-595.
26. Giustina A, Wchrenbcrg WB: Growth hormone ncuroregulation in diabetes mellitus, Trends Endocrinol Mctab 1994:5:73-78.
27. Lewis BM, Dieguez C, Ham J, Page MD, Creagh FM, Peters JR, Scanlon MF: Effects of glucose on thyrotropin releasing hormone, growth hormone-releasing hormone, somatostatin and luteinizing hormone releasing hormone release from rat hypothalamus in vitro, J Ncuroendocrinol 1989:1:437-441.
28. Leal-Cerro A, Pumar A, Garcia E, Dieguez C, Casanueva FF: Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome, Clin Endocrinol 1994:41:649-654.
29. Casanueva F, Burguera B, Pombo C, Alvarez C, Pombo M, Dieguez C: Regulation of GH secretion by glucocorticoids, J Paediatr Endocrinol 1992:5:85-90.
30. Jansson JO, Eden S, lsaksson O: Sexual dimorphism in the control of GH secretion, Endocr Rev 1985;6:128-150.
31. Argentc J, Chowen Breed J, Steiner RA, Clifton DK: Somatostatin messenger RNA in hypothalamic neurones is increased by testosterone through activation of androgen receptors and not by aromatizalion to estradiol, Neuroendo-crinologv 1992;52:342-349.
32. Lago F, Scnaris RM, Entson PC, Dominguez F, Dieguez C: Evidence for the involvement of non-androgcnic testicular factors in the regulation of hypothalamic somatostatin and GHRH mRNA levels, Mol Brain Res 1996:35:220-226.
33. Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabrancs J, Szokc B, Scanlon MF, Shallv AV, Fernandez Cruz A: Free fatty acids block growth hormone (GH) releasing hormone stimulated GH secretion in man by acting directly at pituitary level, J Clin Endocrinol Metab 1987;65:634-642.
34. Alvarez C, Mallo F, Burguera B, Cacicedo L, Dieguez C, Casanueva F: Evidence for a direct pituitary effect of free fatty acid inhibition of GH responses to GHRH in vivo in the rat, Ncuroendocrinology 1991:53:185-189.
35. Senaris RM, Lewis MD, Lago F, Dominguez F, Scanlon MF, Dieguez C: Stimulatory effect of free-fatty acids on growth hormone releasing hormone secretion by fetal rat neurons in monolayer culture, Ncurosci Lett 1992,135: 80-82.
36. Scnaris R, Lago F, Lewis MD, Dominguez F, Scanlon MF, Dieguez C: Effect of free-fatty acids on somatostatin secretion and somatostatin ntRNA levels by fetal rat neurones in monolayer culture, J Mol Endocrinol 1993:10: 207-214.
37. Cordido F, Peino R, Penalva A, Alvarez CV, Casanueva FF, Dieguez C: Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression, J Clin Endocrinol Metab 1996:81:914-918.
38. Bowers CY: Novel GH-rcleasing peptides; in Melmed S (cd): Molecular and Clinical Advances in Pituitary Disorders, Los Angeles, Endocrine Research Incorporated, 1993, pp 153-157.
39. Cheng K, Chan WW, Barreto A Jr., Convey EM, Smith RG: The synergistic effect of His-/>Trp-Ala-Trp-/J-Phe-Lys-NH; on growth hormone (GH)-releasing factor stimulated GH release and intracellular adenosine 3',5'-mono-phosphatc accumulation in rat pituitary cell culture, Endocrinology 1989:129:3337-3342.
40. Dickson SL, Leng G, Dyball REG, Smith RG: Central actions of peptide and non-peptide growth hormone secretagogues in the rat, Neuroendocrinology 1995:61:36-43.
41. Clark RG, Carlsson L, Trojnar J, Robinson ICAF: The effect of growth hormone-releasing peptide and growth hormone releasing factor on conscious and anaesthetized rats, J Ncuroendocrinol 1989:1:249-255.